Genetic predisposition to prostate cancer: Update and future perspectives (Q38226480)

31 August 2017

Genetic predisposition to prostate cancer: Update and future perspectives (English)

1 reference

31 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996773%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Janet L Stanford

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996773%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

2 July 2014

1 reference

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996773%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996773%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996773%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

75-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996773%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Mendelian inheritance of familial prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genetics of prostate cancer: too many loci, too few genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genetic etiology of hereditary prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

The heritability of prostate cancer in the Nordic Twin Study of Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genome-wide association studies in common cancers--what have we learnt?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genetic variants associated with predisposition to prostate cancer and potential clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genome-wide association study of prostate cancer mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Large-scale copy number polymorphism in the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Detection of large-scale variation in the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Copy number variation: new insights in genome diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Structural variants: changing the landscape of chromosomes and design of disease studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

An integrated map of genetic variation from 1,092 human genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A computational framework discovers new copy number variants with functional importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Relating CNVs to transcriptome data at fine resolution: assessment of the effect of variant size, type, and overlap with functional regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Deletions of chromosome 15 as a cause of the Prader-Willi syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Structural variation in the human genome and its role in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Copy number variation in human health, disease, and evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Copy number variation at 1q21.1 associated with neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

The UGT2B17 gene deletion is not associated with prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Germline mutations in HOXB13 and prostate-cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Molecular sampling of prostate cancer: a dilemma for predicting disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

HOXB13 mutations in a population-based, case-control study of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A candidate prostate cancer susceptibility gene at chromosome 17p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Germline BRCA1 mutations increase prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Cancer risks in BRCA2 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Germline Mutations in the BRCA2 Gene and Susceptibility to Hereditary Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

An integrated encyclopedia of DNA elements in the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Variants at IRX4 as prostate cancer expression quantitative trait loci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

The three 'C' s of chromosome conformation capture: controls, controls, controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

The mutational landscape of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

Principal components analysis corrects for stratification in genome-wide association studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.04.021